Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Cerezyme Patent Expiration

Cerezyme is a drug owned by Genzyme Corp. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Aug 27, 2013. Details of Cerezyme's patents and their expiration are given in the table below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5549892 Enhanced in vivo uptake of glucocerebrosidase
Aug, 2013

(11 years ago)

Expired

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

US patents provide insights into the exclusivity only within the United States, but Cerezyme is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Cerezyme's family patents as well as insights into ongoing legal events on those patents.

Cerezyme's Family Patents


Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List


Generic Launch

Generic Release Date:

Cerezyme's generic launch date based on the expiry of its last outstanding patent is estimated to be Aug 27, 2013 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Cerezyme Generics:

There are no approved generic versions for Cerezyme as of now.





About Cerezyme

Cerezyme is a drug owned by Genzyme Corp. It is used for treating Gaucher's disease. Cerezyme uses Imiglucerase as an active ingredient. Cerezyme was launched by Genzyme in 1994.

Approval Date:

Cerezyme was approved by FDA for market use on 23 May, 1994.

Active Ingredient:

Cerezyme uses Imiglucerase as the active ingredient. Check out other Drugs and Companies using Imiglucerase ingredient

Treatment:

Cerezyme is used for treating Gaucher's disease.

Dosage:

Cerezyme is available in injectable form for injection use. Given below is detailed information on Dosage -

Strength Dosage Form Availability Application Pathway
200 UNITS/VIAL INJECTABLE Prescription INJECTION
400 UNITS/VIAL INJECTABLE Prescription INJECTION